2nd Anglo-Swiss Symposium: Using chemical biology to identify new targets for Medicinal Chemistry

1-day symposium organized by the SCS Division of Medicinal Chemistry & Chemical Biology in collaboration with the British colleagues from BMCS of the RSC.

The topic of this second Anglo-Swiss symposium has been selected by our members among several proposals aiming at reinforcing the links between chemical biology, medicinal and agro chemistry, while being of importance in drug discovery and optimization programs.

Download Flyer
Download poster abstracts

Confirmed Speakers:

• Jonas V. Schaefer, Novartis, CH, «DNA-Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery»
• Yimon Aye, EPFL Lausanne, CH, «Within our Control? Leveraging Precision Electrophile Signaling Toward Drug Discovery»
• Maja Köhn, University of Freiburg, D, «Specific Modulators of Protein Phosphatase-1 and their Application in Heart Failure»
• Kristian Strømgaard, University of Copenhagen, DK, «Targeting Protein-Protein Interactions of Receptor Complexes»
• Stephan Sieber, TU Munich, D, «Chemical Tools to Fight Multiresistant Bacteria»
• Mark Frigerio, Abzena, UK, «How Medicinal Chemistry is Validating the Promise of ADCs as a Suitable Targeted Therapy, Delivering Successful Clinical Programs»
• Filip Roudnicky, F. Hoffmann-La Roche, CH, «CRISPR/Cas9 Screening for Novel Target Identification»
• Daniel Romo, Baylor University Texas, US, «Pharmacophore-Directed Retrosynthesis’ Applied to Bioactive Natural Product Synthesis and Cellular Target Identification»

Contact:

Cornelia Zumbrunn
Idorsia Pharmaceuticals Ltd